THEME: "Emerging Perspectives in Neurology and Brain Research"
The University of Sheffield, United Kingdom
Title: Uncovering new targets and therapies for amyotrophic lateral sclerosis (ALS) using artificial intelligence (AI) approaches.
Dr. Monika Myszczynska studies the non-cell
autonomous mechanism of motor neuron disease (MND), focusing on the role of
astrocytes in the disease. She specializes in in vitro disease modelling
and utilizes the models to unravel the mechanism(s) of action of drug
candidates to treat MND. Through her various industrial collaborations, she has
developed an interest in the uses of machine learning in advancing therapies
for neurodegenerative diseases.
glia in CNS disease, drug
discovery for neurodegeneration